These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29510967)

  • 41. Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition.
    Damen L; Donze SH; Kuppens RJ; Bakker NE; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
    Orphanet J Rare Dis; 2020 Jun; 15(1):163. PubMed ID: 32580778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome.
    Wolfgram PM; Carrel AL; Allen DB
    Curr Opin Pediatr; 2013 Aug; 25(4):509-14. PubMed ID: 23782572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES.
    Stipančić G; Požgaj Šepec M; La Grasta Sabolić L
    Acta Clin Croat; 2018 Dec; 57(4):744-755. PubMed ID: 31168212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group.
    Lindgren AC; Hagenäs L; Ritzén EM
    Horm Res; 1999; 51(4):157-61. PubMed ID: 10474015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of growth hormone therapy on cardiac dimensions in children and adolescents with Prader-Willi syndrome.
    Hauffa BP; Knaup K; Lehmann N; Neudorf U; Nagel B
    Horm Res Paediatr; 2011; 75(1):56-62. PubMed ID: 20924154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children.
    Hauffa BP; Petersenn S
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):155-6. PubMed ID: 19178506
    [No Abstract]   [Full Text] [Related]  

  • 47. Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial.
    Reus L; Pelzer BJ; Otten BJ; Siemensma EP; van Alfen-van der Velden JA; Festen DA; Hokken-Koelega AC; Nijhuis-van der Sanden MW
    Res Dev Disabil; 2013 Oct; 34(10):3092-103. PubMed ID: 23886754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of growth hormone on cognitive, motor, and behavioral development in Prader-Willi syndrome children: a meta-analysis of randomized controlled trials.
    Luo Y; Zheng Z; Yang Y; Bai X; Yang H; Zhu H; Pan H; Chen S
    Endocrine; 2021 Feb; 71(2):321-330. PubMed ID: 33222122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of Prader-Labhart-Willi syndrome in children and in adults, with particular emphasis on the treatment with recombinant human growth hormone.
    Drabik M; Lewiński A; Stawerska R
    Pediatr Endocrinol Diabetes Metab; 2022; 28(1):64-74. PubMed ID: 35307998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy.
    Ludwig NG; Radaeli RF; Silva MM; Romero CM; Carrilho AJ; Bessa D; Macedo DB; Oliveira ML; Latronico AC; Mazzuco TL
    Arch Endocrinol Metab; 2016; 60(6):596-600. PubMed ID: 27982202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome.
    Böhm B; Ritzén EM; Lindgren AC
    Acta Paediatr; 2015 Jan; 104(1):59-67. PubMed ID: 25263744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
    Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
    Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of growth hormone treatment or physical training on motor performance in Prader-Willi syndrome: a systematic review.
    Reus L; van Vlimmeren LA; Staal JB; Otten BJ; Nijhuis-van der Sanden MW
    Neurosci Biobehav Rev; 2012 Sep; 36(8):1817-38. PubMed ID: 22652271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy.
    Al-Saleh S; Al-Naimi A; Hamilton J; Zweerink A; Iaboni A; Narang I
    J Pediatr; 2013 Feb; 162(2):263-8.e1. PubMed ID: 22947651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prader-Willi syndrome: who can have growth hormone?
    Stafler P; Wallis C
    Arch Dis Child; 2008 Apr; 93(4):341-5. PubMed ID: 18089632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition.
    Höybye C
    Acta Paediatr; 2015 Apr; 104(4):422-7. PubMed ID: 25557351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.